Falls, Accidental, Quality of Life, Stigma, Urinary Incontinence
Conditions
Keywords
Urinary incontinence, Falls, Quality of life, Stigma, Community-dwelling older women, Continence promotion
Brief summary
To determine whether women exposed to the continence promotion intervention will report improved urinary symptoms and quality of life, and lower incontinence-related stigma and falls than women who receive a control intervention at one-year post-intervention.
Detailed description
This is a cluster-randomized 4-site intervention study testing the effect of a continence-promotion intervention on: 1. Improved urinary symptoms and quality of life 2. Reduction in falls 3. Reduction in stigma A cost-effectiveness component will also be included
Interventions
Interactive group education workshop promoting continence
Interactive group education workshop about general health
Sponsors
Study design
Eligibility
Inclusion criteria
* Women * 65 years and older * Urinary incontinence at least once weekly
Exclusion criteria
* Living in residential or long-term care * Received treatment for incontinence within the past year * Dementia or other neurological conditions that preclude the ability to provide -Informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Self-reported improvement in urinary incontinence | 1 year | Patient global impression of improvement questionnaire Sandvik severity index ICIQ-FLUTS |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Falls | 1 year | Reduction in incontinence-related falls measured by fall diary |
| Reduction in incontinence related stigma and quality of life | 1 year | Measured with the Incontinence Quality of Life questionnaire (IQOL) |
Other
| Measure | Time frame | Description |
|---|---|---|
| Cost-utility of the continence promotion intervention | 1-year | Cost/QALY. Direct costs will include costs related to the intervention as well as health care resource use due to incontinence-associated falls and health care seeking for incontinence will be measured. Indirect costs will be measured such as the time lost from work for a child or spouse to accompany the participant to receive medical treatment for incontinence or falls. The change in utility from the baseline incontinent condition to improved incontinence with increased social participation and decreased stigma on quality of life will be calculated from SF6D utilities derived from the SF-12 questionnaire at baseline and 1-year follow-up. A disease-specific measure, the IQOL is currently undergoing mapping onto the SF-6D to see if it will provide a more responsive indication of improved quality of life than the generic SF-12 measure. |
Countries
Canada, France, United Kingdom